Research - Clinical Research Development Ireland

CRDI Programmes

CRDI works with its partner institutions, and collaborators in academia and industry, to develop and deliver clinical and translational research programmes. We are actively involved in project management and coordination of the following programmes:

Future Investment in Clinical Research

Clinical Research Development Ireland is co-ordinating an exciting new initiative known as the Future Resourcing of Clinical Research (FRCR) which aims to enhance the level of clinical research in Ireland.

Wellcome-HRB ICAT Programme

The Wellcome-HRB Irish Clinical Academic Training (ICAT) Programme is an all-Ireland clinician PhD programme funded primarily by the Wellcome Trust and Health Research Board (HRB). The programme is coordinated by Clinical Research Development Ireland (CRDI).

HRB - CRCI

HRB Clinical Research Coordination Ireland formed in 2015 as an independent integrated national clinical research network, providing centralised support in the conduct of multicentre clinical trials (both commercial and academic) across Ireland.

CRDI / CÚRAM Partnership

CRDI is collaborating with CÚRAM, the SFI Centre for Research in Medical Devices, in its mission to translate research to the clinic and in development and delivery of the centre's education and training programme.

IPCOR

The Irish Prostate Cancer Outcomes Research (IPCOR) Project is a clinically-led study that aims to improve the treatment and care of men diagnosed with prostate cancer in Ireland thus maximising their quality of life.

HRB Neonatal Encephalopathy PhD Training Network (NEPTuNE)

The HRB Neonatal Encephalopathy PhD Training Network (NEPTuNE) is a major collaborative structured PhD research programme led by Neonatal Brain Consortium Ireland (NBCI). CRDI is a core partner of the HRB NEPTuNE.

Corporate Enabling of Clinical Research (CECR)

The rationale for this initiative was the belief that the difficulties experienced by academic institutions would be better addressed in a cooperative manner and with input from all stakeholders across the health sector, academia, funding and regulatory bodies.

CONSCIOUS

CRDI is part of a new Erasmus+ funded programme with European partners: The Curriculum Development of Human Clinical Trials for the Next Generation Biomedical Students (CONSCIOUS)

iProspect

The aim of the Irish PROgramme for Stratified ProstatE Cancer Therapy (iPROSPECT) is to develop and implement informed patient stratification and deliver a programme of stratified oncology for patients with prostate cancer.

CSFP and CTRSP Research

The MMI Clinician Scientist Fellowship and Clinical & Translational Research Scholars Programmes have generated impressive patient-focused research outputs across the five MMI partner institutions.

DCCR

The Dublin Centre for Clinical Research, funded by the Wellcome Trust and the HRB, created a new Clinical Research Facility at TCD / St James’s Hospital and built a network for collaborative clinical research including IT and research nursing support.

ICRIN

The Irish Clinical Research Infrastructure Network was a focused collaboration of the MMI partner institutions to review existing resources, partner with the European Clinical Research Infrastructure Network and develop a national support network for clinical research.

CRDI Research Consortia and Networks

Clinical Research Development Ireland aims to promote a strong multi-disciplinary and cross-institutional collaborative research environment. As such, we are facilitating a central information point that presents an overview of clinical and translational research consortia involving our partner institutions. Here, these research consortia take the opportunity to present a succinct view of their aims and collaborative strengths.

Innovation

INNOVATION-the Irish National Network for Ovarian Cancer Collaboration was established with a mission to integrate patient clinical pathways with cutting edge research to improve diagnosis and treatment of ovarian cancer.

National Prostate Cancer Research Consortium (NPCRC)

The National Prostate Cancer Research Consortium (NPCRC) is a multi-disciplinary, trans-institutional collaboration bringing together researchers from UCD, TCD, UCC, RCSI, DCU, NUI-Galway, Cancer Trials Ireland and the National Cancer Registry in a combined effort to personalise treatment and care for men with prostate cancer to improve outcomes and optimise quality of life.

ARC

ARC was established in 2016 by rheumatologists across Ireland to support research studies and clinical trials activities.

IBN

The Irish Biomarker Network aims to connect scientists, clinicians and industry representatives interested in biomarker research to share expertise and best practice in discovery, translation and commercialisation of biomarkers across disease areas.

NSAI Biotechnology Standards Consultative Committee

Established in 2014, the NSAI Biotechnology Standards Consultative Committee is the national forum for stakeholders in Ireland to keep up to date with international standard development in the field of Biotechnology.

CERVIVA

The Irish Cervical Screening Research (CERVIVA) Consortium, funded by the Health Research Board, is a multi-investigator collaboration encompassing researchers at seven Irish universities, eight hospitals and ten commercial diagnostic/ biotechnology companies.